Lichtenstein AH. Fatty Acids: Trans Fatty Acids. In: Encyclopedia of Food and Health: Elsevier Ltd; 2016. p. 645–8.
Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of non-communicable diseases. World Economic Forum: Geneva; 2011.
Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341:581–5.
European Food Safety Authority. Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J. 2010;8:107.
Mozaffarian D. Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler Suppl. 2006;7:29–32.
European Food Safety Authority (EFSA). Scientific and technical assistance on trans fatty acids. EFSA J. 2018;15:EN-1433.
World Health Organization. Countdown to 2023: WHO report on global trans fat elimination 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Brouwer IA, Wanders AJ, Katan MB. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans--a quantitative review. Plos One. 2010;5:e9434.
Wanders AJ, Zock PL, Brouwer IA. Trans fat intake and its dietary sources in general populations worldwide: a systematic review. Nutrients. 2017;9:840.
Sébédio JL, Christie WW. Metabolism of trans fatty acid isomers. In: Trans Fatty Acids in Human Nutrition. Destaillats F, Sébédio JL, Dionisi F, Chardigny JM, editors. 2nd Edition. Bridgwater: The Oily Press; 2009.
de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978.
Jakobsen MU, Overvad K, Dyerberg J, Heitmann BL. Intake of ruminant trans fatty acids and risk of coronary heart disease. Int J Epidemiol. 2008;37:173–82.
Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr. 2009;63(Suppl 2):S5–21.
Bendsen NT, Christensen R, Bartels EM, Astrup A. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr. 2011;65:773–83.
Oomen CM, Ocke MC, Feskens EJ, van Erp-Baart MA, Kok FJ, Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen elderly study: a prospective population-based study. Lancet. 2001;357:746–51.
Motard-Belanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, et al. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr. 2008;87:593–9.
Gebauer SK, Destaillats F, Dionisi F, Krauss RM, Baer DJ. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. Am J Clin Nutr. 2015;102:1339–46.
Chardigny JM, Destaillats F, Malpuech-Brugere C, Moulin J, Bauman DE, Lock AL, et al. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans fatty acids collaboration (TRANSFACT) study. Am J Clin Nutr. 2008;87:558–66.
Gayet-Boyer C, Tenenhaus-Aziza F, Prunet C, Marmonier C, Malpuech-Brugere C, Lamarche B, et al. Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials. Br J Nutr. 2014;112:1914–22.
Oteng AB, Kersten S. Mechanisms of action of trans fatty acids. Adv Nutr. 2020;11:697–708.
Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell. 2005;120:261–73.
Hirata Y, Takahashi M, Kudoh Y, Kano K, Kawana H, Makide K, et al. Trans-fatty acids promote proinflammatory signaling and cell death by stimulating the apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway. J Biol Chem. 2017;292:8174–85.
Chen CL, Tetri LH, Neuschwander-Tetri BA, Huang SS, Huang JS. A mechanism by which dietary trans fats cause atherosclerosis. J Nutr Biochem. 2011;22:649–55.
Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr. 2005;135:562–6.
Lichtenstein AH, Erkkila AT, Lamarche B, Schwab US, Jalbert SM, Ausman LM. Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis. 2003;171:97–107.
Shahin AM, McGuire MK, Anderson N, Williams J, McGuire MA. Effects of margarine and butter consumption on distribution of trans-18:1 fatty acid isomers and conjugated linoleic acid in major serum lipid classes in lactating women. Lipids. 2006;41:141–7.
Bertschi I, Collomb M, Rist L, Eberhard P, Sieber R, Bütikofer U, et al. Maternal dietary Alpine butter intake affects human milk: fatty acids and conjugated linoleic acid isomers. Lipids. 2005;40:581–7.
Syrén ML, Turolo S, de Marco EA, De Cosmi V, Risé P, Marangoni F, et al. Whole blood fatty acid profile of young subjects and adherence to the Mediterranean diet: an observational cohort study. Lipids Health Dis. 2022;21:23.
Pimentel G, Burton KJ, von Ah U, Butikofer U, Pralong FP, Vionnet N, et al. Metabolic Footprinting of fermented Milk consumption in serum of healthy men. J Nutr. 2018;148:851–60.
Burton KJ, Pimentel G, Zangger N, Vionnet N, Drai J, McTernan PG, et al. Modulation of the peripheral blood transcriptome by the ingestion of probiotic yoghurt and acidified milk in healthy, young men. Plos One. 2018;13:e0192947.
Radtke T, Schmid A, Trepp A, Dahler F, Coslovsky M, Eser P, et al. Short-term effects of trans fatty acids from ruminant and industrial sources on surrogate markers of cardiovascular risk in healthy men and women: a randomized, controlled, double-blind trial. Eur J Prev Cardiol. 2017;24:534–43.
Collomb M, Bühler T. Analyse de la composition en acides gras de la graisse de lait. Mitteilungen aus Lebensmitteluntersuchung und Hygiene. 2000;91:306–32.
Gille D, Zangger N, Soneson C, Butikofer U, Delorenzi M, Schwander F, et al. Caloric dose-responsive genes in blood cells differentiate the metabolic status of obese men. J Nutr Biochem. 2017;43:156–65.
R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna. 2019. https://www.R-project.org.
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide Array probe level data. Biostatistics. 2003;4:249–64.
Gautier L, Cope L, Bolstad BM, Irizarry RA. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307–15.
hgu219.db: Affymetrix Human Genome 219 Plate annotation data (chip hgu219). R package version 3.2.3. https://bioconductor.org/packages/release/data/annotation/html/hgu219.db.html.
Trimigno A, Munger L, Picone G, Freiburghaus C, Pimentel G, Vionnet N, et al. GC-MS based metabolomics and NMR spectroscopy investigation of food intake biomarkers for Milk and cheese in serum of healthy humans. Metabolites. 2018;8:26.
R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna. 2018. https://www.R-project.org.
Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vazquez-Fresno R, et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018;46:D608–17.
Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA, et al. Proposed minimum reporting standards for chemical analysis chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics. 2007;3:211–21.
Ulaszewska MM, Weinert CH, Trimigno A, Portmann R, Andres Lacueva C, Badertscher R, et al. Nutrimetabolomics: an integrative action for Metabolomic analyses in human nutritional studies. Mol Nutr Food Res. 2019;63:e1800384.
Chaleckis R, Meister I, Zhang P, Wheelock CE. Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics. Curr Opin Biotechnol. 2019;55:44–50.
Thevenot EA, Roux A, Xu Y, Ezan E, Junot C. Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. J Proteome Res. 2015;14:3322–35.
Wickham H. ggplot2 elegant graphics for data analysis. New York: Springer-Verlag; 2016.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289–300.
De Livera AM, Bowne JB. metabolomics: Analysis of Metabolomics Data. R package version 0.1.4; 2014.
Murtagh F, Legendre P. Ward's hierarchical agglomerative clustering method: which algorithms implement Ward‘s criterion? J Classif. 2014;31:274–95.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–50.
Wei T, Simko V. R package "corrplot": Visualization of a Correlation Matrix (Version 0.84); 2017.
Kim S. Ppcor: an R package for a fast calculation to semi-partial correlation coefficients. Commun Stat Appl Methods. 2015;22:665–74.
Munger LH, Garcia-Aloy M, Vazquez-Fresno R, Gille D, Rosana ARR, Passerini A, et al. Biomarker of food intake for assessing the consumption of dairy and egg products. Genes Nutr. 2018;13:26.
Albani V, Celis-Morales C, Marsaux CF, Forster H, O'Donovan CB, Woolhead C, et al. Exploring the association of dairy product intake with the fatty acids C15:0 and C17:0 measured from dried blood spots in a multipopulation cohort: findings from the Food4Me study. Mol Nutr Food Res. 2016;60:834–45.
Guertin KA, Moore SC, Sampson JN, Huang WY, Xiao Q, Stolzenberg-Solomon RZ, et al. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. Am J Clin Nutr. 2014;100:208–17.
Saadi HAS. Trans-Fatty Acids. In: Encyclopedia of Toxicology, vol. 4: Elsevier Inc.; 2014. p. 798–801.
Ferlay A, Bernard L, Meynadier A, Malpuech-Brugere C. Production of trans and conjugated fatty acids in dairy ruminants and their putative effects on human health: a review. Biochimie. 2017;141:107–20.
Li C, Richter P, Cobb LK, Kuiper HC, Seymour J, Vesper HW. Dietary Sources of Plasma trans Fatty Acids among Adults in the United States: NHANES 2009–2010. Curr Dev Nutr. 2021;5:nzab063.
Saadatian-Elahi M, Slimani N, Chajes V, Jenab M, Goudable J, Biessy C, et al. Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European prospective investigation into Cancer and nutrition. Am J Clin Nutr. 2009;89:331–46.
Weggemans RM, Rudrum M, Trautwein EA. Intake of ruminant versus industrial trans fatty acids and risk of coronary heart disease – what is the evidence? Eur J Lipid Sci Technol. 2004;106:390–7.
Engel S, Tholstrup T. Butter increased total and LDL cholesterol compared with olive oil but resulted in higher HDL cholesterol compared with a habitual diet. Am J Clin Nutr. 2015;102:309–15.
Oshita T, Toh R, Shinohara M, Mori K, Irino Y, Nagao M, et al. Elevated serum Elaidic acid predicts risk of repeat revascularization after percutaneous coronary intervention in Japan. Circ J. 2019;83:1032–8.
de Roos B, Wanders AJ, Wood S, Horgan G, Rucklige G, Reid M, et al. A high intake of industrial or ruminant trans fatty acids does not affect the plasma proteome in healthy men. Proteomics. 2011;11:3928–34.
van Dijk SJ, Mensink M, Esser D, Feskens EJ, Muller M, Afman LA. Responses to high-fat challenges varying in fat type in subjects with different metabolic risk phenotypes: a randomized trial. Plos One. 2012;7:e41388.
Miller SB. Prostaglandins in health and disease: an overview. Semin Arthritis Rheum. 2006;36:37–49.
Da Silva MS, Bilodeau JF, Larose J, Greffard K, Julien P, Barbier O, et al. Modulation of the biomarkers of inflammation and oxidative stress by ruminant trans fatty acids and dairy proteins in vascular endothelial cells (HUVEC). Prostaglandins Leukot Essent Fatty Acids. 2017;126:64–71.
Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr. 2004;79:606–12.
Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr. 2004;79:969–73.
Allen NE, Grace PB, Ginn A, Travis RC, Roddam AW, Appleby PN, et al. Phytanic acid: measurement of plasma concentrations by gas-liquid chromatography-mass spectrometry analysis and associations with diet and other plasma fatty acids. Br J Nutr. 2008;99:653–9.
Roca-Saavedra P, Marino-Lorenzo P, Miranda JM, Porto-Arias JJ, Lamas A, Vazquez BI, et al. Phytanic acid consumption and human health, risks, benefits and future trends: a review. Food Chem. 2017;221:237–47.
Sá MJ, Rocha JC, Almeida MF, Carmona C, Martins E, Miranda V, et al. Infantile Refsum disease: influence of dietary treatment on plasma Phytanic acid levels. JIMD Rep. 2016;26:53–60.
Lichtenstein AH. Fatty acids: trans fatty acids. In: Encyclopedia of food and Health; 2016. p. 645–8.